Pill with imprint P 119 is White, Capsule-shape and has been identified as Everolimus 2.5 mg. It is supplied by Par Pharmaceutical, Inc.

Everolimus is used in the treatment of Neuroendocrine Carcinoma; Breast Cancer; Organ Transplant, Rejection Prophylaxis; Renal Angiomyolipoma; Tuberous Sclerosis Complex and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).